Article
Inhibition of p53 Mutant Peptide Aggregation In Vitro by Cationic Osmolyte Acetylcholine Chloride.
Protein and peptide letters - 1 Jan 2017
Chen Zhaolin, Kanapathipillai Mathumai
Abstract excerpt
Mutations of tumor suppressor protein p53 are present in almost about 50% of all cancers. It has been reported that the p53 mutations cause aggregation and subsequent loss of p53 function, leading to cancer progression. Here in this study we focus on the inhibitory effects of cationic osmolyte molecules acetylcholine chloride, and choline on an aggregation prone 10 amino acid p53 mutant peptide WRPILTIITL, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
